Page last updated: 2024-10-21

3,4-methylenedioxyamphetamine and Ovarian Neoplasms

3,4-methylenedioxyamphetamine has been researched along with Ovarian Neoplasms in 1 studies

3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.

Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.

Research Excerpts

ExcerptRelevanceReference
"An autocrine role of NGF in breast cancer and epithelial ovarian cancer (EOC) is evident now."1.35Neurotrophin in obstetrics and gynaecology. ( Bose, CK, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bose, CK1

Other Studies

1 other study available for 3,4-methylenedioxyamphetamine and Ovarian Neoplasms

ArticleYear
Neurotrophin in obstetrics and gynaecology.
    Journal of stem cells, 2009, Volume: 4, Issue:4

    Topics: Animals; Breast Neoplasms; Embryo Implantation; Endometriosis; Female; Fetal Growth Retardation; Gyn

2009